Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model.

@article{Uabundit2010CognitiveEA,
  title={Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model.},
  author={Nongnut Uabundit and Jintanaporn Wattanathorn and Supaporn Mucimapura and Kornkanok Ingkaninan},
  journal={Journal of ethnopharmacology},
  year={2010},
  volume={127 1},
  pages={
          26-31
        }
}

Figures from this paper

Neuroprotective Effects of Bacopa monnieri in Experimental Model of Dementia
TLDR
The results suggest therapeutic potential of BM in the treatment of AD associated cognitive decline, as evident by decreased LPO and protein carbonyl levels and restoration in activities of the antioxidant enzymes.
Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease
TLDR
Brahmi promises to be a novel agent in AD; however, further human trials are recommended to verify the efficacy and rule out any side effects as evidenced by the experimental models.
Prevention of age-associated neurodegeneration and promotion of healthy brain ageing in female Wistar rats by long term use of bacosides
TLDR
The results of the present study suggest that bacosides may act as a potential therapeutic intervention in forestalling the deleterious effects of ageing and preventing the age associated pathologies like SDAT.
Experimental and Clinical Evaluation of Nootropic Activity of Bacopa monniera Linn. (Brahmi)
TLDR
Extracts as well as the bacoside preparation have been found safe and well tolerated in healthy volunteers in single dose or chronic administration for several weeks in a number of double blind placebo controlled studies in India and abroad.
Neuro-behavioral modification of Bacopa Monnieri in rotenone induced hemi-Parkinson’s disease model of male Wistar albino rats
TLDR
Bacopa monnieri improves the motor and non-motor symptoms of PD in rat models and the mechanism underlying its usage in Parkinson’s disease is validated in this study.
Protective effect of Picrorhiza kurroa on Alzheimer’s disease induced by aluminium chloride in rats
TLDR
Oral administration of ethanolic extract of Picrorhiza kurroa at doses 200, 400mg/kg body weight showed improve in behavioural parameters when compared to AlCl 3 induced rats, showed increase in superoxide dismutase, catalase, reduced glutathione and decreased levels of malondialdehyde.
Neuropharmacological review of the nootropic herb Bacopa monnieri.
TLDR
This review synthesizes behavioral research with neuromolecular mechanisms putatively involved with the low-toxicity cognitive enhancing action of Bacopa monnieri (BM), a medicinal Ayurvedic herb, to integrate molecular neuroscience with behavioral research.
Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences
TLDR
It is demonstrated that BM is a powerful antioxidant which prevents cognitive impairment, oxidative damage, and morphological changes in the ICV-STZ-infused rats, and may have therapeutic value for the treatment of cognitive impairment.
Standardized Bacopa monnieri extract ameliorates acute paraquat-induced oxidative stress, and neurotoxicity in prepubertal mice brain
TLDR
It is inferred that BM prophylaxis renders the brain resistant to PQ-mediated oxidative perturbations and thus may be better exploited as a preventive approach to protect against oxidative-mediated neuronal dysfunctions.
...
...

References

SHOWING 1-10 OF 31 REFERENCES
Anxiolytic activity of a standardized extract of Bacopa monniera: an experimental study.
  • S. BhattacharyaS. Ghosal
  • Psychology, Biology
    Phytomedicine : international journal of phytotherapy and phytopharmacology
  • 1998
Antioxidant activity ofBacopa monniera in rat frontal cortex, striatum and hippocampus
TLDR
Bacopa monniera (BM) induced a dose‐related increase in SOD, CAT and GPX activities, in all the brain regions investigated, after 14 and 21 days of drug administration, suggesting that the increase in oxidative free radical scavenging activity by BM may explain the cognition‐ facilitating action of BM.
Effect of bacosides, alcoholic extract of Bacopa monniera Linn. (brahmi), on experimental amnesia in mice.
TLDR
It can be concluded that bacosides facilitate anterograde memory and attenuate anterOGrade experimental amnesia induced by scopolamine and sodium nitrite possibly by improving acetylcholine level and hypoxic conditions, respectively.
Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain
TLDR
BBM has potential to modulate the activities of Hsp70, P450 and SOD thereby possibly allowing the brain to be prepared to act under adverse conditions such as stress.
Comparison of Various Extraction Methods of Bacopa monnieri
TLDR
Bacopa monnieri (L.) Wettst has been used in Ayurvedic medicine as nervine tonic for promoting mental health and improving memory brain function and among nine methods, the highest yield was found in the extract obtained from maceration of the plant material in methanol for 3 days.
Bacopa monniera, a reputed nootropic plant: an overview.
  • A. RussoF. Borrelli
  • Medicine
    Phytomedicine : international journal of phytotherapy and phytopharmacology
  • 2005
Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.
TLDR
Recent advances in understanding the function of cholinesterase in the brain and the use of ChE-inhibitors in AD are reviewed and the position that the influence of cholinergic stimulation on amyloid formation is critical in light of the early targeting of thecholinergic basal forebrain in AD is proposed and supported.
Prospects for pharmacological intervention in Alzheimer disease.
TLDR
Alzheimer disease involves neuronal degeneration with impaired cholinergic transmission in the cerebral cortex and hippocampus in areas of the brain particularly associated with memory and higher intellectual functioning, and the association between nonsteroidal anti-inflammatory drugs and a reduced risk of AD has not yet been confirmed.
...
...